These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 12242654)
21. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Tong D; Czerwenka K; Heinze G; Ryffel M; Schuster E; Witt A; Leodolter S; Zeillinger R Clin Cancer Res; 2006 Apr; 12(8):2442-8. PubMed ID: 16638850 [TBL] [Abstract][Full Text] [Related]
22. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
24. A candidate tumor suppressor gene in human breast cancers. Schott DR; Chang JN; Deng G; Kurisu W; Kuo WL; Gray J; Smith HS Cancer Res; 1994 Mar; 54(6):1393-6. PubMed ID: 8137235 [TBL] [Abstract][Full Text] [Related]
25. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205 [TBL] [Abstract][Full Text] [Related]
26. Identification of candidate liver tumor suppressor genes from human 11p11.2 by transcription mapping of microcell hybrid cell lines. Jahn JE; Ricketts SL; Coleman WB Int J Oncol; 2003 Jun; 22(6):1303-10. PubMed ID: 12738998 [TBL] [Abstract][Full Text] [Related]
27. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114 [TBL] [Abstract][Full Text] [Related]
28. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines. Jiang Y; Tong D; Lou G; Zhang Y; Geng J Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070 [TBL] [Abstract][Full Text] [Related]
29. ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2. Jandrig B; Seitz S; Hinzmann B; Arnold W; Micheel B; Koelble K; Siebert R; Schwartz A; Ruecker K; Schlag PM; Scherneck S; Rosenthal A Oncogene; 2004 Dec; 23(57):9295-302. PubMed ID: 15489893 [TBL] [Abstract][Full Text] [Related]
30. Frequent down-regulation of HIVEP2 in human breast cancer. Fujii H; Gabrielson E; Takagaki T; Ohtsuji M; Ohtsuji N; Hino O Breast Cancer Res Treat; 2005 May; 91(2):103-12. PubMed ID: 15868437 [TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Chen C; Sun X; Ran Q; Wilkinson KD; Murphy TJ; Simons JW; Dong JT Oncogene; 2005 May; 24(20):3319-27. PubMed ID: 15735697 [TBL] [Abstract][Full Text] [Related]
32. Deletion at 13q21 is associated with aggressive prostate cancers. Dong JT; Chen C; Stultz BG; Isaacs JT; Frierson HF Cancer Res; 2000 Jul; 60(14):3880-3. PubMed ID: 10919663 [TBL] [Abstract][Full Text] [Related]
33. Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods. Yamamoto F; Yamamoto M Electrophoresis; 2007 Jun; 28(12):1882-95. PubMed ID: 17523142 [TBL] [Abstract][Full Text] [Related]
34. Two regions of deletion in 9p23-24 in sporadic breast cancer. An HX; Claas A; Savelyeva L; Seitz S; Schlag P; Scherneck S; Schwab M Cancer Res; 1999 Aug; 59(16):3941-3. PubMed ID: 10463588 [TBL] [Abstract][Full Text] [Related]
35. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Hiraguri S; Godfrey T; Nakamura H; Graff J; Collins C; Shayesteh L; Doggett N; Johnson K; Wheelock M; Herman J; Baylin S; Pinkel D; Gray J Cancer Res; 1998 May; 58(9):1972-7. PubMed ID: 9581841 [TBL] [Abstract][Full Text] [Related]
37. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations. Jupe ER; Liu XT; Kiehlbauch JL; McClung JK; Dell'Orco RT Cell Growth Differ; 1996 Jul; 7(7):871-8. PubMed ID: 8809404 [TBL] [Abstract][Full Text] [Related]
38. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828 [TBL] [Abstract][Full Text] [Related]
39. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
40. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]